<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Open Congress : Blog Articles for S.316 Preserve Access to Affordable Generics Act</title>
  <link href="http://www.opencongress.org/bill/110-s316/atom_blogs" rel="self"/>
  <link href="http://www.opencongress.org/bill/110-s316/blogs" rel="alternate"/>
  <updated>2008-12-08T00:00:00Z</updated>
  <author>
    <name>opencongress.org</name>
  </author>
  <id>tag:opencongress.org,2007:/bill/blog/40206</id>
  <entry>
    <title>09.12.2008: Literarisches Bollwerk (Tageszeitung junge Welt)</title>
    <link href="http://www.jungewelt.de/2008/12-09/001.php" rel="alternate"/>
    <id>tag:opencongress.org,2008-12-08:/commentary/3633790</id>
    <updated>2008-12-08T00:00:00Z</updated>
    <author>
      <name>junge Welt </name>
    </author>
    <content type="html">
5 Vgl. Gerrard Winstanley, Gleichheit im Reiche der Freiheit, Leipzig 1986, S. 316 6 Milton (wie Anm. 3), S. 70 (Pro populo Anglicano defensio secunda, 1654) 7 Milton, Das verlorene Paradies (deutsch/englisch), Frankfurt 2008, S. 322 ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.jungewelt.de/2008/12-09/001.php&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Rez. NG: J. Lindenlaub: Die Finanzierung des Aufstiegs von Krupp ...</title>
    <link href="http://hsozkult.geschichte.hu-berlin.de/rezensionen/2008-2-188" rel="alternate"/>
    <id>tag:opencongress.org,2008-11-26:/commentary/3606173</id>
    <updated>2008-11-26T00:00:00Z</updated>
    <author>
      <name>H-Soz-u-Kult </name>
    </author>
    <content type="html">
Auch in diesem Teil seiner Untersuchung liefert Lindenlaub interessante neue Erkenntnisse, wie die Tatsache, dass in der Verwaltung Krupps schon viele Aufgabebereiche moderner Controllingabteilungen abgedeckt wurden (S. 316-318). ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://hsozkult.geschichte.hu-berlin.de/rezensionen/2008-2-188&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>&#226;&#8364;&#382;Bauchaufsatz&#226;&#8364;&#339;: &#195;&#339;ber den Antrieb meines Willens zu schreiben</title>
    <link href="http://annetts-literarische-gedankenwelt.blogspot.com/2008/11/bauchaufsatz-ber-den-antrieb-meines.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-11-03:/commentary/3257898</id>
    <updated>2008-11-03T00:00:00Z</updated>
    <author>
      <name>Annetts literarische Gedankenwelt </name>
    </author>
    <content type="html">
... vorbestimmt sei und die Menschen sich dem Schicksal oder einer Macht hingeben m&#195;&#188;ssten, sondern dass in diesen Zivilisationsprozess eingegriffen werden kann &quot;aufgrund der Kenntnis ihrer ungeplanten Gesetzm&#195;&#164;&#195;&#376;igkeit.&quot; (Bd. II, S. 316). &lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://annetts-literarische-gedankenwelt.blogspot.com/2008/11/bauchaufsatz-ber-den-antrieb-meines.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Martha Muchow | Biographie</title>
    <link href="http://www.fembio.org/biographie.php/frau/biographie/martha-muchow/" rel="alternate"/>
    <id>tag:opencongress.org,2008-09-21:/commentary/3650243</id>
    <updated>2008-09-21T00:00:00Z</updated>
    <author>
      <name>Neue Biographien auf fembio.org </name>
    </author>
    <content type="html">
S. 316-321 und 346-352. Muchow, Martha (1925): Zur Problematik der Testpsychologie im allgemeinen und einiger Ordnungstests im besonderen. In: Stern, William (Hg.): Neue Beitr&#195;&#164;ge zur Theorie und Praxis der Intelligenzpr&#195;&#188;fung. Leipzig. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.fembio.org/biographie.php/frau/biographie/martha-muchow/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Zehn Minuten Gl&#195;&#188;ck</title>
    <link href="http://windhauch.bplaced.net/zehn-minuten-glueck/" rel="alternate"/>
    <id>tag:opencongress.org,2008-06-12:/commentary/2356268</id>
    <updated>2008-06-12T00:00:00Z</updated>
    <author>
      <name>windhauch </name>
    </author>
    <content type="html">
(S.316). Das ist zum Heulen: Zum Heulen sch&#195;&#182;n, dass er diese zehn Minuten erleben durfte. Zum Heulen schrecklich, dass er in 80 Jahren nur diese zehn Minuten getan hat, was er wirklich wollte. Und es ist zum Heulen, dass ich selbst die ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://windhauch.bplaced.net/zehn-minuten-glueck/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Chirag Enterprise</title>
    <link href="http://geizposten.com/chirag-enterprise/" rel="alternate"/>
    <id>tag:opencongress.org,2008-04-20:/commentary/2081182</id>
    <updated>2008-04-20T00:00:00Z</updated>
    <author>
      <name>Berlin kijiji </name>
    </author>
    <content type="html">
S.316 allen cap screws as per drawings, s. S. Nut&amp;amp; lock nut(304q/316q), s. S. Washer. SS Spring washer(square&amp;amp; flat), s. S. Cheese/round head screwsas per is- 1366 a2 304q/as per bs - 450 a2 304q/s. S. Csk mach screw as per is - 1365 ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://geizposten.com/chirag-enterprise/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>RE:Facharbeit?</title>
    <link href="http://www.besteantwort.com/viewtopic.php?f=16&amp;amp;t=74113" rel="alternate"/>
    <id>tag:opencongress.org,2008-04-06:/commentary/2011941</id>
    <updated>2008-04-06T00:00:00Z</updated>
    <author>
      <name>Beste Antwort </name>
    </author>
    <content type="html">
25), M&#195;&#188;ller-Wassermann (2000, S. 316 ff.), Furchtlos (2002, S. 23 f.) und Nachtigall (2002c, S. 234 &#226;&#8364;&#8220; 236). Anders bei Wieser (1987, S. 43). o Beispiel 3: Nach Stein (1988, S. 25) zeichnet sich der Hochleistungssport ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.besteantwort.com/viewtopic.php?f=16&amp;amp;t=74113&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Talking about your Generation</title>
    <link href="http://www.lebenshaus-alb.de/magazin/004844.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-02-07:/commentary/1598790</id>
    <updated>2008-02-07T00:00:00Z</updated>
    <author>
      <name>Lebenshaus Schw&#228;bische Alb </name>
    </author>
    <content type="html">
Elias 1992, aaO, S. 316. Wenn auch im Hinblick auf die deutsche Geschichte formuliert, weist er damit bereits &#195;&#188;ber das konkrete Beispiel hinaus. Denn diese Art von Konflikten existiert in jeder Gesellschaft (in unterschiedlicher ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.lebenshaus-alb.de/magazin/004844.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Brunhild Krueger &#195;&#188;ber ein Buch von Robert Laughlin</title>
    <link href="http://www.jocelyne-lopez.de/blog/?p=179" rel="alternate"/>
    <id>tag:opencongress.org,2008-02-02:/commentary/1560861</id>
    <updated>2008-02-02T00:00:00Z</updated>
    <author>
      <name>Untitled </name>
    </author>
    <content type="html">
Die Frage heute hei&#195;&#376;t (S. 316 - er stellt sie nicht selbst, sondern legt sie anderen in den Mund): &#226;&#8364;&#382;Ist Einstein &#195;&#188;berhaupt noch relevant?&#226;&#8364;* Und Laughlin erkl&#195;&#164;rt, da&#195;&#376; genau das das Problem der Emergenz ist - es gibt wichtigeres: die ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.jocelyne-lopez.de/blog/?p=179&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>US pushes bill to promote competitive presence of generic drug manft.</title>
    <link href="http://ipminds.wordpress.com/2007/03/07/us-pushes-bill-to-promote-competitive-presence-of-generic-drug-manft/" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-07:/commentary/382784</id>
    <updated>2007-03-07T00:00:00Z</updated>
    <author>
      <name>ipmINDs </name>
    </author>
    <content type="html">
The bipartisan Preserve Access to Affordable Generics Act (S. 316) would prohibit brand-name drug companies from exploiting a loophole in the Hatch-Waxman Act to pay generic drug companies to delay entry of new generic medicines into ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://ipminds.wordpress.com/2007/03/07/us-pushes-bill-to-promote-competitive-presence-of-generic-drug-manft/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>praktischer Wertnihilismus</title>
    <link href="http://grunzochse.blogspot.com/2007/03/vor-etwa-einem-halben-jahr-stolperte.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-06:/commentary/382677</id>
    <updated>2007-03-06T00:00:00Z</updated>
    <author>
      <name>Der Grunzochse </name>
    </author>
    <content type="html">
... so scheint es mir &#8211; wohl sogar deutliche und eindeutige Bekenntnisse zur Hochwertigkeit der Demokratie, ja: der freiheitlich-demokratischen Grundordnung, als &#8222;planm&#228;&#223;ige Unterdr&#252;ckung des kritischen Denkens&#8220; (S. 316) abzulehnen. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://grunzochse.blogspot.com/2007/03/vor-etwa-einem-halben-jahr-stolperte.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Panel Passes Bipartisan Bill To Stop Payoffs That Delay Generic ...</title>
    <link href="http://infringement.blogs.com/philip_brooks_patent_infr/2007/02/panel_passes_bi.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-26:/commentary/345292</id>
    <updated>2007-02-26T00:00:00Z</updated>
    <author>
      <name>Philip Brooks&amp;#39; Patent Infringement Updates </name>
    </author>
    <content type="html">
The bipartisan Preserve Access to Affordable Generics Act (S. 316) would prohibit brand-name drug companies from exploiting a loophole in the Hatch-Waxman Act to pay generic drug companies to delay entry of new generic medicines into ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://infringement.blogs.com/philip_brooks_patent_infr/2007/02/panel_passes_bi.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Senate Panel Approves Bill To Ban Some Drug Pat...</title>
    <link href="http://traderegulation.blogspot.com/2007/02/senate-panel-approves-bill-to-ban-some.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-23:/commentary/478612</id>
    <updated>2007-02-23T00:00:00Z</updated>
    <author>
      <name>Trade Regulation Talk </name>
    </author>
    <content type="html">
The committee passed the bill&#8212;the &amp;quot;Preserve Access to Affordable Generics Act&amp;quot; (S. 316)&#8212;on February 15, clearing the measure for consideration by the full Senate. The bill&amp;#39;s supporters say it would lead to more robust competition by ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://traderegulation.blogspot.com/2007/02/senate-panel-approves-bill-to-ban-some.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Senate Judiciary Committee Approves Bill That Would Prevent Drug ...</title>
    <link href="http://www.medicallead.com/senate-judiciary-committee-approves-bill-that-would-prevent-drug-companies-from-conspiring-to-block-market-entry-of-generics/" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-20:/commentary/365080</id>
    <updated>2007-02-20T00:00:00Z</updated>
    <author>
      <name>medicallead.com </name>
    </author>
    <content type="html">
The Senate Judiciary Committee on Thursday approved legislation (S 316) that would prohibit brand-name pharmaceutical companies from paying generic drug companies to delay market introduction of generic competitors, CQ Today reports. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.medicallead.com/senate-judiciary-committee-approves-bill-that-would-prevent-drug-companies-from-conspiring-to-block-market-entry-of-generics/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Senate Judiciary Committee Approves Bill That Would Prevent Drug ...</title>
    <link href="http://topicexchange.com/t/medical/2007/2/20/#_888662" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-20:/commentary/407330</id>
    <updated>2007-02-20T00:00:00Z</updated>
    <author>
      <name>Topic Exchange: Channel &amp;#39;medical&amp;#39; </name>
    </author>
    <content type="html">
via Medical Buzz: The Senate Judiciary Committee on Thursday approved legislation (S 316) that would prohibit brand-name pharmaceutical companies from paying generic drug companies to delay market introduction of g...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://topicexchange.com/t/medical/2007/2/20/#_888662&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Senate Judiciary Committee Approves Bill That Would Prevent Drug ...</title>
    <link href="http://www.zapptor.com/index.php?topic_id=70095" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-20:/commentary/817496</id>
    <updated>2007-02-20T00:00:00Z</updated>
    <author>
      <name>Zapptor </name>
    </author>
    <content type="html">
The Senate Judiciary Committee on Thursday approved legislation S 316 that would prohibit brand45name pharmaceutical companies from paying generic drug companies to delay market introduction of generic competitors, CQ Today reports. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.zapptor.com/index.php?topic_id=70095&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Senate Judiciary Committee Approves Bill That Would Prevent Drug ...</title>
    <link href="http://topicexchange.com/t/medical/2007/2/20/#_888764" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-20:/commentary/304281</id>
    <updated>2007-02-20T00:00:00Z</updated>
    <author>
      <name>Topic Exchange: Channel &amp;#39;medical&amp;#39; </name>
    </author>
    <content type="html">
via Medical Buzz: The Senate Judiciary Committee on Thursday approved legislation (S 316) that would prohibit brand-name pharmaceutical companies from paying generic drug companies to delay market introduction of g...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://topicexchange.com/t/medical/2007/2/20/#_888764&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Panel Passes Bipartisan Bill To Stop Payoffs That Delay Generic ...</title>
    <link href="http://www.einnews.com/iowa/news.php?wid=112968168" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-16:/commentary/382669</id>
    <updated>2007-02-16T00:00:00Z</updated>
    <author>
      <name>EIN News: Iowa Business News </name>
    </author>
    <content type="html">
members, Senators Herb Kohl (D-Wisc.), Chuck Grassley (R-Iowa), Russ Feingold (D-Wisc.), and Charles Schumer (D-NY). ... To Affordable Generics Act (S. 316) Executive Business Meeting February 15, 2007 2007 Senator Kohl ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.einnews.com/iowa/news.php?wid=112968168&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Patent Reform is in the Air</title>
    <link href="http://1fp.us/2007/02/16/patent-reform-is-in-the-air/" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-15:/commentary/444493</id>
    <updated>2007-02-15T00:00:00Z</updated>
    <author>
      <name>Freepress </name>
    </author>
    <content type="html">
It would add the following language: `Notwithstanding any other provision of law, no patent may be obtained for a nucleotide sequence, or its functions or correlations, or the naturally occurring products it specifies.&#8217;. S. 316, on the ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://1fp.us/2007/02/16/patent-reform-is-in-the-air/&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Bill Aimed at Prohibiting Reverse Payment Settlements Clears ...</title>
    <link href="http://www.orangebookblog.com/2007/02/bill_aimed_at_p.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-15:/commentary/267425</id>
    <updated>2007-02-15T00:00:00Z</updated>
    <content type="html">
The Senate Judiciary Committee passed the &amp;quot;Preserve Access to Affordable Generics Act&amp;quot; (S. 316) today by unanimous consent. If enacted, the bill would prohibit &amp;quot;reverse payment&amp;quot; settlements of Hatch-Waxman litigation, ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.orangebookblog.com/2007/02/bill_aimed_at_p.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Patent Reform is in the Air</title>
    <link href="http://www.patentlyo.com/patent/2007/02/patent_reform_i.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-15:/commentary/281958</id>
    <updated>2007-02-15T00:00:00Z</updated>
    <author>
      <name>Patently-O: Patent Law Blog </name>
    </author>
    <content type="html">
It would add the following language: `Notwithstanding any other provision of law, no patent may be obtained for a nucleotide sequence, or its functions or correlations, or the naturally occurring products it specifies.&amp;#39;. S. 316, on the ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.patentlyo.com/patent/2007/02/patent_reform_i.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>This Week&amp;#39;s Senate Committee Schedule</title>
    <link href="http://bobgeiger.blogspot.com/2007/02/this-weeks-senate-committee-schedule.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-05:/commentary/281957</id>
    <updated>2007-02-05T00:00:00Z</updated>
    <author>
      <name>bobgeiger.com </name>
    </author>
    <content type="html">
S.316, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. S.236, to require reports to Congress on ... S. 316: Preserve Access to Affordable Generics Act ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://bobgeiger.blogspot.com/2007/02/this-weeks-senate-committee-schedule.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Committee Hearing: Senate Judiciary</title>
    <link href="http://www.govtrack.us/congress/committee.xpd?id=SSJU" rel="alternate"/>
    <id>tag:opencongress.org,2007-02-03:/commentary/213828</id>
    <updated>2007-02-03T00:00:00Z</updated>
    <author>
      <name>govtrack.us Monitored Events </name>
    </author>
    <content type="html">
S. 316 : Preserve Access to Affordable Generics Act. S. 236 : Federal Agency Data Mining Reporting Act of 2007. S. Res. 36 : A resolution honoring women&amp;#39;s health advocate Cynthia Boles Dailard. S. Res. 37 : A resolution designating ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.govtrack.us/congress/committee.xpd?id=SSJU&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>S. 316: Preserve Access to Affordable Generics Act (GovTrack.us)</title>
    <link href="http://www.govtrack.us/congress/bill.xpd?bill=s110-316" rel="alternate"/>
    <id>tag:opencongress.org,2007-01-18:/commentary/3327751</id>
    <updated>2007-01-18T00:00:00Z</updated>
    <author>
      <name>GovTrack.us Tracked Events </name>
    </author>
    <content type="html">
A bill in the US Congress: A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.govtrack.us/congress/bill.xpd?bill=s110-316&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
</feed>
